Publications & Press

DARWEN^TM AI’s Validation and Recognition in the Public Domain

Manuscript

Automating Access to Real World Evidence

Journal of Thoracic Oncology Clinical and Research Reports

May 17, 2022

News

Takeda Canada Innovation Challenge Awarded to Pentavere to Accelerate Rare Disease Diagnosis and Care Using New AI Technology

Newswire

May 11, 2022

Abstract

Developing a Standardized Framework for Curating Oncology Datasets Generated By Manual Abstraction and Artificial Intelligence

American Association for Cancer Research Annual Meeting 2022

March 1, 2022

News

COVID the Change-Maker: Lessons for Specialty Healthcare

20 Sense

January 20, 2022

News

Harnessing the Power of AI to Help Patients Live Longer

Toronto Star

December 18, 2021

Abstract

Exploring Treatment Patterns and Outcomes of Patients with Advanced Lung Cancer (aLC) Using Artificial Intelligence (AI)-Extracted Data

Supplement, Annals of Oncology

December 1, 2021

News

AI Making Progress in Collaborative Projects Across Canada

Canadian Healthcare Technology Magazine

November 4, 2021

Abstract

Vedolizumab Therapeutic Drug Monitoring and Real-World Outcomes in Inflammatory Bowel Disease

United European Gastroenterology Journal

October 2, 2021

Abstract

Validation of Scalable, Automated Data Extraction in an Advanced Lung Cancer Patient Population

Journal of Thoracic Oncology

October 1, 2021

Abstract

The Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation, and Clinical Outcomes in Inflammatory Bowel Disease in the Real-World Setting

Journal of Crohn's and Colitis

May 27, 2021

460 College Street, Suite 301
Toronto, ON
M6G 1A1, Canada

101 Avenue of the Americas, 3rd Floor
New York, NY
10013, USA

All rights reserved 2023 © Pentavere Research Group Inc.